Cordarone tablet labels and packages

Revision as of 17:19, 12 March 2014 by Ahmed Zaghw (talk | contribs) (Ahmed Zaghw moved page CORDARONE tablet labels and packages to Cordarone tablet labels and packages)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Amiodarone
Cordarone tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov
Nexterone injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Amiodarone
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

[1]

References

  1. "CORDARONE (AMIODARONE HYDROCHLORIDE) TABLET [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]".

Adapted from the FDA Package Insert.